-- Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (dual-NMR) agonist which uses a novel approach of activating NOP and MOP receptors to work synergistically to treat pain ...
Scientists have developed a new gene therapy that quiets pain at its source in the brain—without the addictive risks of opioids. Using AI to map how pain is processed, they created a targeted “off ...
More good news in the battle against opioid addiction. Scientists have reopened research into a class of opioids that were ...
A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity. That’s what scientists at a leading research institute have found. In a ...
SEVEN NEWS. HEY! WELCOME BACK. NEW PAIN MEDICATION HAS BEEN APPROVED BY THE FDA. IT SUPPOSEDLY NON-ADDICTIVE DARLENE MELENDEZ SPOKE WITH. UNM HEALTH EXPERT DOCTOR ASH ON HOW THIS WORKS. THIS NEW DRUG ...
In my years as a nurse working in a drug detox unit, I’ve witnessed both the crushing grip of addiction and the grueling journey of recovery. I’ve held patients’ hands through the agony of withdrawal, ...
Fibromyalgia and chronic pain create a "fertile breeding ground" for self-medication and iatrogenic addiction. . Fibromyalgia involves abnormal pain processing; the brain struggles to turn off pain ...
During my 30 years in the Indiana Senate, I witnessed numerous pieces of legislation aimed at toughening our drug policies and penalties. In my final years, I authored a series of bills that focused ...
During my 30 years in the Indiana Senate, I witnessed numerous pieces of legislation aimed at toughening our drug policies and penalties. In my final years, I authored a series of bills that focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results